LATS1 and cholangiocarcinoma: In a three-dimensional culture system that mimics the TME knockdown of LATS1/2 was found to activate YAP and significantly promote CC cell proliferation as well as AREG secretion, indicating that the Hippo pathway retains its oncogenic function in a context more closely resembling in vivo conditions (17).